Procalcitonin in liver transplant patients - Yet another stone turned

Critical Care

Volumn 12, Issue 1, 2008, Pages

  Jensen, Jens Ulrik ^a,b   Lundgren, Jens D ^b,c  

^a Mental Health Center Glostrup   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN; ANTIINFECTIVE AGENT; CALCITONIN; PROTEIN PRECURSOR;

BACTERIAL INFECTION; CALCITONIN BLOOD LEVEL; CRITICAL ILLNESS; DISEASE MARKER; HUMAN; IMMUNOMODULATION; INTENSIVE CARE; LEUKOCYTE COUNT; LIVER TRANSPLANTATION; NOTE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEPSIS; BLOOD; MORTALITY; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; HUMANS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS;

EID: 45549091693     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6221     Document Type: Note

References (10)

1. Zazula R Prucha M Tyll T Kieslichova E Induction of procalcitonin in liver transplant patients treated with anti-thymocyte globulin Crit Care 2007, 11:R131. 10.1186/cc6202 18088403
2. Alberti C Brun-Buisson C Goodman SV Guidici D Granton J Moreno R Smithies M Thomas O Artigas A Le Gall JR European Sepsis Group Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients Am J Respir Crit Care Med 2003, 168:77-84. 10.1164/rccm.200208-785OC 12702548
3. Jensen JU Heslet L Jensen TH Espersen K Steffensen P Tvede M Procalcitonin increase in early identification of critically ill patients at high risk of mortality Crit Care Med 2006, 34:2596-2602. 10.1097/01.CCM.0000239116.01855.61 16915118
4. Kumar A Roberts D Wood KE Light B Parrillo JE Sharma S Suppes R Feinstein D Zanotti S Taiberg L Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 2006, 34:1589-1596. 10.1097/01.CCM.0000217961.75225.E9 16625125
5. Castelli GP Pognani C Meisner M Stuani A Bellomi D Sgarbi L Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction Crit Care 2004, 8:R234-R242. 522844 15312223 10.1186/cc2877
6. Müller B Becker KL Schächinger H Rickenbacher PR Huber PR Zimmerli W Ritz R Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit Crit Care Med 2000, 28:977-983. 10.1097/ 00003246-200004000-00011 10809269
7. Tang BM Eslick GD Craig JC McLean AS Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: Systematic review and meta-analysis Lancet Infect Dis 2007, 7:210-217. 10.1016/ S1473-3099(07)70052-X 17317602
8. Gaïni S Koldkjaer OG Pedersen C Pedersen SS Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: A prospective study Crit Care 2006, 10:R53. 1550885 16569262 10.1186/cc4866
9. Lindberg M Hole A Johnsen H Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery Scand J Clin Lab Invest 2002, 62:189-194. 10.1080/003655102317475443 12088337
10. Kuse ER Jaeger K Procalcitonin increase after anti-CD3 monoclonal antibody therapy does not indicate infectious disease Transpl Int 2001, 14:55. 10.1111/j.1432-2277.2001.tb00011.x 11263558